Janus Henderson Group
MNTA

Janus Henderson Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Janus Henderson Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,488,914
Closed -$49.5M – 1393
2020
Q2 		$49.5M Buy
1,488,914
+1,472,872
+9,181% +$46.9M 0.03% 493
2020
Q1 		$436K Buy
+16,042
New +$447K ﹤0.01% 1192
2018
Q4 		– Sell
-1,642,494
Closed -$43.2M – 1455
2018
Q3 		$43.2M Sell
1,642,494
-566,492
-26% -$15.3M 0.02% 631
2018
Q2 		$45.2M Buy
2,208,986
+336,859
+18% +$7.23M 0.03% 581
2018
Q1 		$34M Buy
+1,872,127
New +$31.2M 0.02% 650

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janus Henderson Group's MNTA Position: Q3 2020 in Review

Janus Henderson Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 1,488,914 shares — an estimated $49.5M sold.

Janus Henderson Group first reported a position in MNTA in Q1 2018 and held it in 5 quarters. The position peaked at $49.5M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Janus Henderson Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Janus Henderson Group sold 1,488,914 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $49.5M.
  • Janus Henderson Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
  • Janus Henderson Group's Momenta Pharmaceuticals, Inc. position peaked at $49.5M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.